Personalized genomic analyses for cancer mutation discovery and interpretation.
about
Practical aspects of NGS-based pathways analysis for personalized cancer science and medicineGenomic characterization of esophageal squamous cell carcinoma: Insights from next-generation sequencingGenomic alterations in pancreatic cancer and their relevance to therapyUsing large-scale genomics data to identify driver mutations in lung cancer: methods and challengesNot All Next Generation Sequencing Diagnostics are Created Equal: Understanding the Nuances of Solid Tumor Assay Design for Somatic Mutation DetectionNext-generation sequencing to guide cancer therapyMolecular Technologies in the Clinical Diagnostic LaboratoryIntegrating next-generation sequencing into clinical oncology: strategies, promises and pitfallsCirculating tumor DNA as a liquid biopsy target for detection of pancreatic cancerValidation of biomarkers to predict response to immunotherapy in cancer: Volume I - pre-analytical and analytical validationIntegrating cancer genomic data into electronic health recordsPD-1 Blockade in Tumors with Mismatch-Repair DeficiencyThe next generation of metastatic melanoma: uncovering the genetic variants for anti-BRAF therapy responseReal-world data in the molecular era-finding the reality in the real world.Mutation based treatment recommendations from next generation sequencing data: a comparison of web toolsData Interoperability of Whole Exome Sequencing (WES) Based Mutational Burden Estimates from Different LaboratoriesFindings made in gene panel to whole genome sequencing: data, knowledge, ethics - and consequences?The impact of tumor profiling approaches and genomic data strategies for cancer precision medicine.Assigning clinical meaning to somatic and germ-line whole-exome sequencing data in a prospective cancer precision medicine study.Comparison of the seleno-transcriptome expression between human non-cancerous mammary epithelial cells and two human breast cancer cell linesIntegrated analysis of gene expression and copy number identified potential cancer driver genes with amplification-dependent overexpression in 1,454 solid tumors.Clinical Implementation of Integrated Genomic Profiling in Patients with Advanced Cancers.Genomic mutation-driven metastatic breast cancer therapy: a single center experienceGermline Variants in Targeted Tumor Sequencing Using Matched Normal DNA.An unusual genomic variant of pancreatic ductal adenocarcinoma with an indolent clinical course.Clinical implications of genomic alterations in the tumour and circulation of pancreatic cancer patientsMismatch repair deficiency predicts response of solid tumors to PD-1 blockade.Defining "mutation" and "polymorphism" in the era of personal genomics.Whole exome sequencing (WES) on formalin-fixed, paraffin-embedded (FFPE) tumor tissue in gastrointestinal stromal tumors (GIST).Comparison of genetic variants in matched samples using thesaurus annotation.Structure-Based Analysis Reveals Cancer Missense Mutations Target Protein Interaction InterfacesPilot Study of a Next-Generation Sequencing-Based Targeted Anticancer Therapy in Refractory Solid Tumors at a Korean InstitutionBeyond genomics: critical evaluation of cell line utility for ovarian cancer researchPitfalls of improperly procured adjacent non-neoplastic tissue for somatic mutation analysis using next-generation sequencing.Clinical utility of circulating tumor DNA for molecular assessment in pancreatic cancer.Comprehensive detection of germline variants by MSK-IMPACT, a clinical diagnostic platform for solid tumor molecular oncology and concurrent cancer predisposition testing.Systematic Prioritization of Druggable Mutations in ∼5000 Genomes Across 16 Cancer Types Using a Structural Genomics-based ApproachGermline Findings in Tumor-Only Sequencing: Points to Consider for Clinicians and LaboratoriesIdentification of a Novel Pathogenic Germline KDR Variant in Melanoma.The genomic landscape of response to EGFR blockade in colorectal cancer.
P2860
Q26748603-A762CC9A-5B25-4E4E-8FD5-E864A69B5559Q26768533-5D6CE83D-7224-42B0-A1EC-D34CE9E10040Q26781443-58908407-DC54-4E1A-B8A2-9B0527043485Q26800833-568496D5-0BC3-4284-ACDA-970D90CA5E31Q26801745-60ACCAF0-5621-4BFA-BB44-517EB5390966Q26801946-75A5853E-23DF-4777-8E08-C5DD1601B92EQ26996463-BED53675-D332-4732-A95A-242A9B454A23Q28066709-B97E9A48-2DE2-4209-BEBE-656BA35DDFC4Q28069755-AF004A09-3AC5-4994-ACA3-5EAF71740F1AQ28075719-63ADDC02-5587-4DD8-83C2-1C92A6238735Q28077310-92940319-EED2-43E7-BDB4-0FC0C7D134B0Q28262647-681FF35F-71D3-4C8A-8B3F-3AE3D353C697Q30384301-C84FD2D0-8813-434F-BD0C-27E95EA1FD78Q31023009-4F79D0FC-69D9-473B-B00F-74635016CD6DQ31058925-547A716B-3F0D-4974-AB0E-913C40001724Q31089220-B921A56D-714E-425E-8200-09E3803FC5C0Q31114379-92C06C32-0497-4971-ACB1-BFDA5410F6F1Q31117752-41A443F8-76D6-46F8-86C1-225346A82A75Q31157014-BD845F4C-C655-412D-96E1-68019865EF20Q33599250-A30D8F83-DC11-4407-9021-7B1491AEDA48Q33670296-89E1864E-7777-444B-9AFB-273040AA1D4BQ33685000-158EBD65-4843-415C-A643-07DAC1E449BBQ33688687-1B3EFDAD-57B5-40E0-A5DB-FF63AEFF0818Q33817011-30593B49-94C9-4FAC-BE2D-01278F2DFEBCQ33865090-33590C58-99C6-46E0-AC5C-F09C643F5A1FQ34483980-5867D2D7-FD09-422E-B6C1-65B71012366AQ34557699-39E25FE1-B412-447D-A732-68421E4CD66CQ35691099-B7998B83-50D8-4AFC-A8E8-0AB3CF925FB3Q35831238-EA05F63D-387F-4E24-B98B-9894BACB482DQ35834698-5757E55D-306A-4352-AC60-D7CC3F57D377Q35979091-2F6D2E9A-6B12-4931-86F9-D6771698580DQ35997083-D2236FC9-C23E-4616-9020-4D2607CE4180Q36104020-E4289B12-7844-459C-93F0-9E26C8946278Q36166879-B1CD479A-7735-4282-BFB7-F4464D5E8F8EQ36376138-24619986-A975-4F0B-BE61-5F30BB28F484Q36376718-3490A4A5-A1C1-4D95-BF11-6DBF89ACEB78Q36539506-6C143F84-7DBA-4807-8A7B-9F7609CBBEA7Q36847816-E2983F25-C27F-42CB-8ED0-B9858E0F6AB5Q36902033-92290947-D1B6-4809-9C8B-7ACA716C8F93Q36930106-809F5D8D-DE58-4CE0-AAB2-490434806759
P2860
Personalized genomic analyses for cancer mutation discovery and interpretation.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Personalized genomic analyses for cancer mutation discovery and interpretation.
@ast
Personalized genomic analyses for cancer mutation discovery and interpretation.
@en
type
label
Personalized genomic analyses for cancer mutation discovery and interpretation.
@ast
Personalized genomic analyses for cancer mutation discovery and interpretation.
@en
prefLabel
Personalized genomic analyses for cancer mutation discovery and interpretation.
@ast
Personalized genomic analyses for cancer mutation discovery and interpretation.
@en
P2093
P2860
P50
P1476
Personalized genomic analyses for cancer mutation discovery and interpretation.
@en
P2093
Bryan Chesnick
David R Riley
Derek Murphy
Eniko Papp
Karli Lytle
Kevin G Galens
Manish Shukla
Mark Sausen
Maura Kadan
P2860
P304
P356
10.1126/SCITRANSLMED.AAA7161
P407
P577
2015-04-01T00:00:00Z